Phibro Animal Health (PAHC)
(Delayed Data from NSDQ)
$22.01 USD
+1.12 (5.36%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $22.00 -0.01 (-0.05%) 7:28 PM ET
2-Buy of 5 2
A Value A Growth F Momentum A VGM
- YR Estimate
- 06/30/2024
- 06/30/2023
- 06/30/2022
- 06/30/2021
- 06/30/2020
- Revenue - Line of Business (LOBR)
- Net Sales: Animal Health
- 706.50
- 659.90
- 607.06
- 545.72
- 526.90
- Revenue - Line of Business (LOBR)
- Net Sales: Animal Health: MFAs and other
- 421.00
- 387.30
- 361.54
- 330.02
- 322.30
- Revenue - Line of Business (LOBR)
- Net Sales: Animal Health: Nutritional specialties
- 164.70
- 172.50
- 157.20
- 142.76
- 129.26
- Revenue - Line of Business (LOBR)
- Net Sales: Animal Health: Vaccines
- 120.90
- 100.00
- 88.32
- 72.94
- 75.34
- Revenue - Line of Business (LOBR)
- Net Sales: Mineral Nutrition
- 243.70
- 242.70
- 259.51
- 220.56
- 214.41
- Revenue - Line of Business (LOBR)
- Net Sales: Performance Products
- 67.50
- 75.40
- 75.69
- 67.07
- 59.04
- Revenue - Geographic (GEOR)
- Net Sales by Region: United States
- 584.76
- 578.77
- 561.80
- 494.89
- 471.94
- Revenue - Geographic (GEOR)
- Net Sales by Region: Latin America and Canada
- 247.71
- 219.85
- 191.05
- 166.33
- 158.94
- Revenue - Geographic (GEOR)
- Net Sales by Region: Europe, Middle East and Africa
- 121.98
- 117.82
- 122.48
- 114.13
- 112.18
- Revenue - Geographic (GEOR)
- Net Sales by Region: Asia Pacific
- 63.23
- 61.46
- 66.93
- 58.01
- 57.30
- Income - Line of Business (LOBI)
- Adjusted EBITDA: Animal Health
- 145.60
- 136.14
- 124.11
- 123.95
- 123.11
- Income - Line of Business (LOBI)
- Adjusted EBITDA: Mineral Nutrition
- 16.40
- 17.42
- 24.04
- 17.12
- 14.68
- Income - Line of Business (LOBI)
- Adjusted EBITDA: Performance Products
- 7.70
- 9.35
- 8.71
- 9.44
- 4.53
- Income - Line of Business (LOBI)
- Adjusted EBITDA: Corporate
- -58.50
- -50.15
- -45.77
- -42.62
- -40.18